IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma

Journal: Nature Cell Biology

Published: 2019-08-01

DOI: 10.1038/s41556-019-0363-9

Affiliations: 36

Authors: 57

Go to article
Institutions Share
UC Division of Hematology and Oncology, United States of America (USA) 0.20
Graduate School of Biomedical and Health Sciences (BIMES), HU, Japan 0.10
Division of Gene Regulation, Keio University, Japan 0.07
Institute for Advanced Biosciences (IAB), Keio University, Japan 0.07
UAB Department of Neurosurgery, United States of America (USA) 0.05
UCLA Department of Pathology and Laboratory Medicine, United States of America (USA) 0.05
Human Biology Division, FHCRC, United States of America (USA) 0.04
UC Cancer and Blood Diseases Institute, United States of America (USA) 0.04
Division of Transgenic Animal Science, KU, Japan 0.04
Department of Biochemistry and Integrative Medical Biology, Keio University, Japan 0.04
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Germany 0.03
Center for Molecular Biomedicine (CMB), Germany 0.03
Children's Medical Center Research Institute (CRI), United States of America (USA) 0.02
Cancer Metabolism Laboratory, The Francis Crick Institute, United Kingdom (UK) 0.02
UC Department of Neurology, United States of America (USA) 0.02
Ludwig Institute for Cancer Research San Diego Branch, United States of America (USA) 0.02
Department of Neurosurgery, MGH, United States of America (USA) 0.02
Harvard Medical School (HMS), United States of America (USA) 0.02
UC Department of Internal Medicine, United States of America (USA) 0.02
National Hospital Organization Osaka National Hospital, Japan 0.02
DKFZ-ZMBH Alliance, Germany 0.02
School of Medicine, TWMU, Japan 0.02
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, United States of America (USA) 0.01
Annette G. Strauss Center for Neuro-Oncology, UT Southwestern Medical Center, United States of America (USA) 0.01
Department of Internal Medicine, UT Southwestern Medical Center, United States of America (USA) 0.01
Japan Agency for Medical Research and Development (AMED), Japan 0.01
Artificial Intelligence Research Center (AIRC), AIST, Japan 0.01
USC Children's Hospital Los Angeles (CHLA), United States of America (USA) 0.01
UK Department of Pathology and Laboratory Medicine, United States of America (USA) 0.01
Department of Pathology, NU, United States of America (USA) 0.01
Department of Neurological Surgery, NU, United States of America (USA) 0.01
USC Department of Pathology, United States of America (USA) 0.01
UC Division of Pathology, United States of America (USA) 0.01
Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, United States of America (USA) 0
Department of Cancer Biology, UC, United States of America (USA) 0
University of Cincinnati Neuroscience Institute (UCNI), United States of America (USA) 0

Return